- Day 1: Appoint the sponsor, project owner and clinical/legal approvers; identify urgent continuity issues.
- Day 2: Map money flows, contracts, current partners and upcoming prescription demand using aggregate data.
- Day 3: Separate approved-product, manufacturer-access, clinic-stock and any proposed compounding workstreams.
- Day 4: Open the evidence register; assemble the legal-review brief and standard RFI.
- Day 5: Contact appropriate counterparties, obtain specialist-review scopes and publish the project gates.
Do not spend the first week building an enormous supplier directory. Build a decision process that can reject unsuitable arrangements quickly and test the remaining ones properly.
Answers stay in this session unless you choose to save. No account needed.
Sources cited on this page
See the section’s source register for the research context.
Section sources →